On May 3 2022, Flanders Vaccine is organizing a COVID-19 symposium: from epidemiology to intervention at the Communicatie Campus in Ghent.

Renowned experts from the Flanders Vaccine network will share their latest scientific data on the current situation and expectations and needs for the future regarding COVID-19 vaccine developments, evolution of variants, perspectives for therapies and global access to COVID-19 vaccination.

Key questions will be addressed during the Q&A session, moderated by Prof. Pierre Van Damme, UAntwerp and Prof. Johan Neyts, KU Leuven. Kate Antrobus, Univercells' Chief Investment Officer, will be one of the key speakers during the event.

More information can be found here: https://flandersvaccine.be/events/covid-19-symposium-from-epidemiology-to-intervention/